AKAN Akanda Corp. - Common Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jun 9, 2026
$1.98
· of 52w range
· above low
· to high
$1.9452w low
$78.9052w high
P/E
-0.0
EPS
$-662.22
Revenue
$258.1K
your badges
52W Range
$2–$79
Analyst Rating
·
Price Target
·
P/E
-0.0
ROE
31.2%
Net Profit Margin
-467.1%
Your badge strip is empty — pin a metric anywhere on this page.
AKAN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.98
P/E
-0.0
EPS
$-662.22
Revenue
$258.1K
ROE
31.2%
52W Range
$2–$79
AKAN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| April 13, 2026 | 1-for-5 | Reverse |
| Jan. 12, 2026 | 1-for-5 | Reverse |
| Aug. 26, 2025 | 1-for-3 | Reverse |
| Nov. 14, 2024 | 1-for-2 | Reverse |
| May 23, 2024 | 1-for-40 | Reverse |
| March 9, 2023 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$258.1K2020-12-31 → 2025-12-31
EPS$-662.222019-12-31 → 2025-12-31
Free Cash Flow$-8M2022-12-31 → 2025-12-31
Net margin-467.1%2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | AKAN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.05Y avg ≈-24.2 | ≈-24.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | AKAN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | -60.5%5Y avg ≈-326.1% | ≈-326.1% | · | · | |
| Operating Margin | -1931.0%5Y avg ≈-4036.9% | ≈-4036.9% | · | · | |
| EBITDA Margin | -1762.9%5Y avg ≈-3783.6% | ≈-3783.6% | · | · | |
| Pretax Margin | -18157.2% | · | · | · | |
| Net Profit Margin | -467.1%5Y avg ≈-4504.3% | ≈-4504.3% | · | · | |
| ROA | -17.1%5Y avg ≈-76.5% | ≈-76.5% | · | · | |
| ROE | 31.2%5Y avg ≈-389.6% | ≈-389.6% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | AKAN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 0.65Y avg ≈0.6 | ≈0.6 | · | · | |
| Quick Ratio | 0.35Y avg ≈0.4 | ≈0.4 | · | · | |
| Interest Coverage | -1058.95Y avg ≈-394.1 | ≈-394.1 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | AKAN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.05Y avg ≈0.1 | ≈0.1 | · | · | |
| Receivables Turnover | 0.35Y avg ≈1.9 | ≈1.9 | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $258.1K | · | $423.7K | $3M | $41.4K | $2.1K | |
| Cost of Revenue | $414.1K | · | $364.3K | $566.3K | $43.0K | $1.8K | |
| Gross Profit | $-156.0K | · | $59.3K | $3M | $-1.6K | $-58.2K | |
| SG&A Expense | $2M | $1M | $323.3K | $3M | $170.9K | $229.7K | |
| Operating Income | $-5M | $-4M | $-4M | $-20M | $-3M | $-2M | |
| Interest Expense | $4.7K | · | $121.4K | · | $10.5K | $645.2K | |
| Interest Income | · | $3.0K | $39 | $886 | $90 | $10.2K | |
| Pretax Income | $-47M | $-4M | · | · | · | · | |
| Net Income | $-1M | · | $-32M | $-12M | $-8M | $-2M | |
| EPS (Basic) | $-662.22 | $-276.40 | $-573.11 | $-3.86 | $-0.50 | $-0.18 | |
| EPS (Diluted) | $-662.22 | $-276.40 | $-573.11 | $-3.86 | $-0.50 | $-0.18 | |
| Shares (Basic) | 68,941 | 14,819 | 56,316 | 2,993,009 | 16,223,996 | 13,129,212 | |
| Shares (Diluted) | · | 1,042,014 | 56,316 | 2,993,009 | 16,223,996 | 13,129,212 | |
| EBITDA | $-5M | $-4M | $-6M | $-17M | $-7M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $503.6K | $4M | $82.8K | $228.8K | $3M | $13.5K | |
| Receivables | $1M | $370.5K | $284.5K | $1M | $242.4K | · | |
| Inventory | · | · | $1M | $1M | · | $611 | |
| Current Assets | $4M | $5M | $2M | $4M | $4M | $127.6K | |
| PP&E (Net) | $2M | $2M | $3M | $12M | $2M | $2M | |
| Goodwill | $40M | · | · | · | · | · | |
| Intangibles | · | $15.8K | $4M | $22M | $259.1K | $321.4K | |
| Total Assets | $6M | $8M | $9M | $39M | $8M | $4M | |
| Accounts Payable | $3M | $3M | $6M | $7M | $680.3K | $183.9K | |
| Current Liabilities | $6M | $4M | $10M | $9M | $8M | $3M | |
| Total Liabilities | $18M | $4M | $13M | $12M | $10M | $9M | |
| Retained Earnings | $-103M | $-57M | $-53M | $-21M | $-13M | $-5M | |
| Stockholders' Equity | $-12M | $4M | $-4M | $27M | $-2M | $-5M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $433.7K | $137.3K | $209.2K | $4M | $478 | $248.7K | |
| Other Non-cash | $-6M | $-25.4K | $26M | $-3M | · | · | |
| Operating Cash Flow | $-7M | $-4M | $-2M | $-11M | $-7M | · | |
| CapEx | $1M | $2M | $1.5K | $310.9K | $576.5K | $439.1K | |
| Investing Cash Flow | $-7M | $-1M | $24.9K | $-4M | $-576.5K | $-432.2K | |
| Financing Cash Flow | $12M | $9M | $1M | $14M | $11M | $1M | |
| Free Cash Flow | $-8M | $-6M | $-2M | $-12M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | -60.5% | 24.9% | 5.2% | 124.8% | -1725.1% | · | |
| Operating Margin | -1931.0% | -523.8% | -465.3% | -770.2% | -16494.2% | · | |
| Net Margin | -467.1% | -489.6% | -1494.2% | -445.0% | -19625.9% | · | |
| Pretax Margin | -18157.2% | · | · | · | · | · | |
| EBITDA Margin | -1762.9% | -506.9% | -267.0% | -632.8% | -15748.4% | · | |
| ROA | -17.1% | -48.9% | -134.9% | -49.6% | -132.0% | · | |
| ROE | 31.2% | -1830.0% | -279.8% | -94.4% | 224.8% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | 1.4 | 0.2 | 0.4 | 0.5 | · | |
| Quick Ratio | 0.3 | 1.2 | 0.0 | 0.2 | 0.5 | · | |
| Interest Coverage | -1058.9 | -43.8 | -686.7 | -175.0 | -6.3 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | · | |
| Inventory Turnover | · | · | 1.6 | 1.1 | · | · | |
| Receivables Turnover | 0.3 | 2.6 | 2.8 | 3.5 | 0.3 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | · | $0.80 | $0.48 | $0.09 | $0.00 | · | |
| Cash Flow / Share | · | $-3.82 | $-0.33 | $-0.38 | · | · | |
| EPS (TTM) | $-662.22 | $-276.40 | $-573.11 | $-3.86 | $-0.50 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $258.1K | · | $423.7K | $3M | $41.4K | · | |
| Net Income TTM | $-1M | · | $-32M | $-12M | $-8M | · | |
| P/E | -0.0 | -0.0 | -0.2 | -96.5 | · | · | |
| Earnings Yield | -144905.9% | -5528.0% | -521.0% | -1.0% | · | · |
No quarterly filings for AKAN
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $258.1K | · | $423.7K | $3M | $41.4K |
| Gross Margin % | -60.5% | 24.9% | 5.2% | 124.8% | -1725.1% |
| Operating Margin % | -1931.0% | -523.8% | -465.3% | -770.2% | -16494.2% |
| Net Income | $-1M | · | $-32M | $-12M | $-8M |
| Diluted EPS | $-662.22 | $-276.40 | $-573.11 | $-3.86 | $-0.50 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 0.6 | 1.4 | 0.2 | 0.4 | 0.5 |
| Quick Ratio | 0.3 | 1.2 | 0.0 | 0.2 | 0.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-8M | $-6M | $-2M | $-12M | · |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Halo Collective Inc. (the “Reporting Person”) ×2 filings | Feb. 20, 2024 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 1 insider · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% owner | Jan. 16, 2026 S | 7,816 | 1 | 1 | $30,500 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Jun 9, 2026